Failure of alemtuzumab therapy in three patients with MOG antibody associated disease

Abstract Background Myelin Oligodendrocyte Glycoprotein antibody-associated disease (MOGAD) is most classically associated in both children and adults with phenotypes including bilateral and recurrent optic neuritis (ON) and transverse myelitis (TM), with the absence of brain lesions characteristic...

Full description

Bibliographic Details
Published in:BMC Neurology
Main Authors: Sinali O. Seneviratne, Mark Marriott, Sudarshini Ramanathan, Wei Yeh, Fabienne Brilot-Turville, Helmut Butzkueven, Mastura Monif
Format: Article
Language:English
Published: BMC 2022-03-01
Subjects:
Multiple sclerosis
Demyelination
Autoimmune
MOG antibody
Encephalomyelitis
Online Access:https://doi.org/10.1186/s12883-022-02612-6

Internet

https://doi.org/10.1186/s12883-022-02612-6

Similar Items